IRF4 and colonic neoplasm: Our in vivo assays further revealed that the inoculation of IRF4-overexpressed SW480 cells effectively attenuated the colon cancer tissue damage, whereas IRF4 knockdown aggravated the colon cancer tissue damage in colon cancer mouse model.